期刊文献+

抗CD59对CVF激活人血小板的影响 被引量:1

Effect of anti-CD59 on CVF-induced platelet activation
下载PDF
导出
摘要 目的 :研究补体的激活对人血小板的作用及其抗CD5 9对该作用的影响。方法 :应用眼镜蛇毒因子(CVF)制成补体活化血小板的模型 ,通过测定健康成年男性血小板的聚集及释放曲线 ,观察抗CD5 9应用前后补体对血小板变形、聚集及释放功能的影响。结果 :CVF能诱导健康成年男性的血小板显著、持久地变形和释放 ,但不能诱导血小板聚集。当CVF浓度在 12 .5 - 5 0 0g/L范围内 ,血小板的最大变形幅度与CVF浓度的对数呈线性相关 (r=0 970 ,P <0 .0 1,n =36 )。抗CD5 9能增强健康成年男性血小板的最大变形幅度 ,并与剂量相关 ,其血小板最大变形幅度的最大增加值为空白对照的 1.36倍 (P <0 .0 1)。同时抗CD5 9也促进补体诱导的血小板ATP分泌增多。结论 :活化补体后能诱导健康成年男性血小板发生变形、释放 ,但不诱导血小板的聚集 ,且抗CD5 AIM: To study the reactions of human platelet to active complement and the effects of anti-CD59 on human platelet activation induced by complement. METHODS: By applying CVF to activate complement, the platelet aggregation and release reactions induced by activated complement with or without appling anti-CD59 with different doses to block the complement modulative protein CD59 in healthy individuals, were observed. RESULTS: CVF induced platelet release and significant and lasting metamorphosis in healthy individuals, but platelet aggregation was not observed. CVF-induced platelet metamorphosis showed positive linear correlation to lg concentration of CVF (r=0 970. P<0.01. n=36) . Anti-CD59 enhanced CVF-induced platelet shape change with a dose-dependent manner. The max enhancive ratio of platelet shape change was 1.36( P <0.01). Anti-CD59 enhanced platelet ATP release induces by CVF. CONCLUSION: Complement activated by CVF induces significant and lasting platelet metamorphosis and release reaction, but dose not induce platelet aggregation in healthy adult males. Anti-CD59 promotes the platelet reactions induced by active complement.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2003年第5期696-698,共3页 Chinese Journal of Pathophysiology
关键词 抗CD59 眼镜蛇毒因子 补体 激活 血小板 Complement Blood platelets Anti-CD59
  • 相关文献

参考文献8

  • 1古亚娟,黄守坚,孙家钧.人红细胞膜CD59的分离及对依赖补体血小板损伤的保护[J].中国药理学通报,1998,14(6):512-515. 被引量:8
  • 2Jiang H, Wagner E, Zhang H, et al. Complement I inhibitor is a regulator of the alternative complement pathway[J]. J Exp Med, 2001,194(11): 1609- 1616.
  • 3Fu Q, Mcphie P, Gowda DC. Methionine modification impairs the C5- cleavage function of cobra venom factor- dependent C3/C5 convertase[J]. Biochem Mol Biol Int, 1998,45( 1):133- 144.
  • 4Xu Y, Ma M, Ippolito C,C, et al. Complement activation in factor D - deficient mice[J]. Proc Natl Acad Sci USA, 2001,98(25) : 14577 - 14582.
  • 5Rinder CS, Rinder HM, Smith BR, et al. Blockade of C5a and C5b - 9 generation inhibits leukocyte and platelet activation during extracorporeal circulation[J]. J clin Invest, 1995,96(3) : 1564 - 1572.
  • 6Rinder CS, Binder HM, Smith MJ, et al. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelets but not leukocyte activation[J]. J Thorac Cardiovasc Surg, 1999, 118(3):460-466.
  • 7Farkas I, Baranyi L, Ishikawa Y, et al. CD59 blocks not only the insertion of C9 into MAC but inhibits iron channel formation by homologous C5b- 8 as well as C5b - 9[J]. J Physiol,2002,539(pt2) :537 - 545.
  • 8Shichishima T, Saitoh Y, Terasawa T, et al. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype [ J ]. Br J Haematol, 1999,104(2):303-306.

共引文献7

同被引文献11

  • 1Diagouraga B,Grichine A,Fertin A,et al.Motor-driven marginal band coiling promotes cell shape change during platelet activation[J].J Cell Biol,2014,204(2):177-185.
  • 2Ghoshal K,Bhattacharyya M.Overview of Platelet Physiology:Its hemostatic and nonhemostatic role in disease pathogenesis[J].Scientific World Journal,2014(2014):781857.
  • 3Aslan JE,Baker SM,Loren CP,et al.The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation[J].Am J Physiol Cell Physiol,2013,305(5):C519-C528.
  • 4Beaumont DO,Whitten KW,Mock RG,et al.Measuring platelet function with platelet shape change,an early event in aggregation[J].Thromb Res,1989,53(2):109-127.
  • 5Santos-Martínez MJ,Prina-Mello A,Medina C,et al.Analysis of platelet function:role of microfluidics and nanodevices[J].Analyst,2011,136(24):5120-5126.
  • 6Aburima A,Wraith KS,Raslan Z,et al.cAMP signaling regulates platelet myosin light chain(MLC)phosphorylation and shape changethrough targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway[J].Blood,2013,122(20):3533-3545.
  • 7Lu WJ,Wu MP,Lin KH,et al.Hinokitiol is a novel glycoprotein VI antagonist on human platelets[J].Platelets,2014 Jan 16.[Epub ahead of print].
  • 8Essex DW,Li M,Miller A,et al.Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation[J].Biochemistry,2001,40(20):6070-6075.
  • 9Fuentes E,Forero-Doria O,Carrasco G,et al.Effect of tomato industrial processing on phenolic profile and antiplatelet activity[J].Molecules,2013,18(9):11526-11536.
  • 10Canales A,Benedi J,Bastida S,et al.The effect of consuming meat enriched in walnut paste on platelet aggregation and thrombogenesis varies in volunteers with different apolipoprotein A4 genotype[J].Nutr Hosp,2010,25(5):746-754.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部